Publications:
A selected list of publications:
Ling Walter, Hillhouse Maureen, Domier Catherine, Doraimani Geetha, Hunter Jeremy, Thomas Christie, Jenkins Jessica, Hasson Albert, Annon Jeffrey, Saxon Andrew, Selzer Jeffrey, Boverman Joshua, Bilangi Richard
Buprenorphine tapering schedule and illicit opioid use
Addiction (Abingdon, England),
2009; 104(2):
256-65.
Yu Elmer, Miotto Karen, Akerele Evaristo, Montgomery Ann, Elkashef Ahmed, Walsh Robert, Montoya Ivan, Fischman Marian W, Collins Joseph, McSherry Frances, Boardman Kathy, Davies David K, O'Brien Charles P, Ling Walter, Kleber Herbert, Herman Barbara H
A Phase 3 placebo-controlled, double-blind, multi-site trial of the
alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal
Drug and alcohol dependence,
2008; 97(1-2):
158-68.
Shoptaw Steven, Heinzerling Keith G, Rotheram-Fuller Erin, Steward Trevor, Wang Jason, Swanson Aimee-Noelle, De La Garza Richard, Newton Tom, Ling Walter
Randomized, placebo-controlled trial of bupropion for the treatment of
methamphetamine dependence
Drug and alcohol dependence,
2008; 96(3):
222-32.
Humeniuk Rachel, Ali Robert, Babor Thomas F, Farrell Michael, Formigoni Maria L, Jittiwutikarn Jaroon, de Lacerda Roseli B, Ling Walter, Marsden John, Monteiro Maristela, Nhiwatiwa Sekai, Pal Hemraj, Poznyak Vladimir, Simon Sara
Validation of the Alcohol, Smoking And Substance Involvement Screening
Test (ASSIST)
Addiction (Abingdon, England),
2008; 103(6):
1039-47.
Yu Elmer, Miotto Karen, Akerele Evaristo, O'Brien Charles P, Ling Walter, Kleber Herbert, Fischman Marian W, Elkashef Ahmed, Herman Barbara H, Al-Ghananeem Abeer M
Clinical pharmacokinetics of lofexidine, the alpha 2-adrenergic
receptor agonist, in opiate addicts plasma using a highly sensitive
liquid chromatography tandem mass spectrometric analysis
The American journal of drug and alcohol abuse,
2008; 34(5):
611-6.
Elkashef Ahmed, Rawson Richard A, Smith Edwina, Pearce Valerie, Flammino Frank, Campbell Jan, Donovick Roger, Gorodetzky Charles, Haning William, Mawhinney Joseph, McCann Michael, Weis Dennis, Williams Lorie, Ling Walter, Vocci Frank
The NIDA Methamphetamine Clinical Trials Group: a strategy to increase
clinical trials research capacity
Addiction (Abingdon, England),
2007; 102 Suppl 1(2):
107-13.
Shoptaw Steven, Huber Alice, Peck James, Yang Xiaowei, Liu Juanmei, Jeff Dang Juanmei, Roll John, Shapiro Benjamin, Rotheram-Fuller Erin, Ling Walter
Randomized, placebo-controlled trial of sertraline and contingency
management for the treatment of methamphetamine dependence
Drug and alcohol dependence,
2006; 85(1):
12-8.
Venneman Sandy, Leuchter Andrew, Bartzokis George, Beckson Mace, Simon Sara L, Schaefer Melodie, Rawson Richard, Newton Tom, Cook Ian A, Uijtdehaage Sebastian, Ling Walter
Variation in neurophysiological function and evidence of quantitative
electroencephalogram discordance: predicting cocaine-dependent
treatment attrition
The Journal of neuropsychiatry and clinical neurosciences,
2006; 18(2):
208-16.
London Edythe D, Berman Steven M, Voytek Bradley, Simon Sara L, Mandelkern Mark A, Monterosso John, Thompson Paul M, Brody Arthur L, Geaga Jennifer A, Hong Michael S, Hayashi Kiralee M, Rawson Richard A, Ling Walter
Cerebral metabolic dysfunction and impaired vigilance in recently
abstinent methamphetamine abusers
Biological psychiatry,
2005; 58(10):
770-8.
Ling Walter, Amass Leslie, Shoptaw Steve, Annon Jeffrey J, Hillhouse Maureen, Babcock Dean, Brigham Greg, Harrer Judy, Reid Malcolm, Muir Joan, Buchan Betty, Orr Debbie, Woody George, Krejci Jonathan, Ziedonis Douglas, Ziedonis Douglas
A multi-center randomized trial of buprenorphine-naloxone versus
clonidine for opioid detoxification: findings from the National
Institute on Drug Abuse Clinical Trials Network
Addiction (Abingdon, England),
2005; 100(8):
1090-100.
Voytek Bradley, Berman Steven M, Hassid B Daniel, Simon Sara L, Mandelkern Mark A, Brody Arthur L, Monterosso John, Ling Walter, London Edythe D
Differences in regional brain metabolism associated with marijuana
abuse in methamphetamine abusers
Synapse (New York, N.Y.),
2005; 57(2):
113-5.
Raisch Dennis W, Fudala Paul J, Saxon Andrew J, Walsh Robert, Casadonte Paul, Ling Walter, Johnson Bankole A, Malkerneker Usha, Ordorica Patricia, Williford William O, Sather Mike R
Pharmacists' and technicians' perceptions and attitudes toward
dispensing buprenorphine/ naloxone to patients with opioid dependence
Journal of the American Pharmacists Association : JAPhA,
2005; 45(1):
23-32.
Thompson Paul M, Hayashi Kiralee M, Simon Sara L, Geaga Jennifer A, Hong Michael S, Sui Yihong, Lee Jessica Y, Toga Arthur W, Ling Walter, London Edythe D
Structural abnormalities in the brains of human subjects who use
methamphetamine
The Journal of neuroscience : the official journal of the Society for Neuroscience,
2004; 24(26):
6028-36.
Amass Leslie, Ling Walter, Freese Thomas E, Reiber Chris, Annon Jeffrey J, Cohen Allan J, McCarty Dennis, Reid Malcolm S, Brown Lawrence S, Clark Cynthia, Ziedonis Douglas M, Krejci Jonathan, Stine Susan, Winhusen Theresa, Brigham Greg, Babcock Dean, Muir Joan A, Buchan Betty J, Horton Terry
Bringing buprenorphine-naloxone detoxification to community treatment
providers: the NIDA Clinical Trials Network field experience
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions,
2004; 13 Suppl 1(3):
S42-66.
London Edythe D, Simon Sara L, Berman Steven M, Mandelkern Mark A, Lichtman Aaron M, Bramen Jennifer, Shinn Ann K, Miotto Karen, Learn Jennifer, Dong Yun, Matochik John A, Kurian Varughese, Newton Thomas, Woods Roger, Rawson Richard, Ling Walter
Mood disturbances and regional cerebral metabolic abnormalities in
recently abstinent methamphetamine abusers
Archives of general psychiatry,
2004; 61(1):
73-84.
Fudala Paul J, Bridge T Peter, Herbert Susan, Williford William O, Chiang C Nora, Jones Karen, Collins Joseph, Raisch Dennis, Casadonte Paul, Goldsmith R Jeffrey, Ling Walter, Malkerneker Usha, McNicholas Laura, Renner John, Stine Susan, Tusel Donald, Tusel Donald
Office-based treatment of opiate addiction with a sublingual-tablet
formulation of buprenorphine and naloxone
The New England journal of medicine,
2003; 349(10):
949-58.
Shoptaw Steve, Rotheram-Fuller Erin, Yang Xiaowei, Frosch Dominick, Nahom Debbie, Jarvik Murray E, Rawson Richard A, Ling Walter
Smoking cessation in methadone maintenance
Addiction (Abingdon, England),
2002; 97(10):
1317-28; discussion 1325.
Ling Walter
Cynthia's Dilemma
The American journal of bioethics : AJOB,
2002; 2(2):
55-6.
Miotto Karen, McCann Michael, Basch Janice, Rawson Richard, Ling Walter
Naltrexone and dysphoria: fact or myth?
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions,
2002; 11(2):
151-60.
Ling Walter, Shoptaw Steven, Hillhouse Maureen, Bholat Michelle A, Charuvastra Charles, Heinzerling Keith, Chim David, Annon Jeffrey, Dowling Patrick T, Doraimani Geetha
Double-blind placebo-controlled evaluation of the PROMETAâ„¢ protocol
for methamphetamine dependence
Addiction (Abingdon, England),
2012; 107(2):
361-9.